| Patricia Rena Dejesus, | |
|
29 Dogwood Dr, Middletown, NY 10940-1801 | |
| (845) 341-8008 | |
| Not Available |
| Full Name | Patricia Rena Dejesus |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 24 Years |
| Location | 29 Dogwood Dr, Middletown, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083217954 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 085061 (New York) | Primary |
| Entity Name | Second Chance Counseling Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265190094 PECOS PAC ID: 6002207719 Enrollment ID: O20220106000836 |
News Archive
"We welcome the Pew organization to our longstanding fight to improve the lives of American children by helping more of them enjoy the good oral health that too many of them now lack.
BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
The Seventh International Conference on Cell Therapy for Cardiovascular Disease sponsored by the Cardiovascular Research Foundation (CRF) is a comprehensive program dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.
BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.
Three months after undergoing renal denervation —a procedure that delivers energy to overactive nerves leading to the kidney to decrease their activity—patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared with patients who underwent a sham procedure and experienced no major adverse effects, according to results from the SPYRAL-HTN OFF MED pivotal trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Rena Dejesus, 29 Dogwood Dr, Middletown, NY 10940-1801 Ph: (845) 341-8008 | Patricia Rena Dejesus, 29 Dogwood Dr, Middletown, NY 10940-1801 Ph: (845) 341-8008 |
News Archive
"We welcome the Pew organization to our longstanding fight to improve the lives of American children by helping more of them enjoy the good oral health that too many of them now lack.
BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
The Seventh International Conference on Cell Therapy for Cardiovascular Disease sponsored by the Cardiovascular Research Foundation (CRF) is a comprehensive program dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.
BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.
Three months after undergoing renal denervation —a procedure that delivers energy to overactive nerves leading to the kidney to decrease their activity—patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared with patients who underwent a sham procedure and experienced no major adverse effects, according to results from the SPYRAL-HTN OFF MED pivotal trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
› Verified 8 days ago
Ms. Shahla Gorovoy, PHD Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 225 Dolson Ave, Middletown, NY 10940 Phone: 845-325-6202 | |
Ms. Tunya Denise Harris, LCSW-R Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 36 Brick Pond Rd, Middletown, NY 10940 Phone: 347-219-1866 Fax: 845-342-8600 | |
Dr. Steven J Murphy, PHD, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 141 Dunning Rd, Middletown, NY 10940 Phone: 845-344-3755 Fax: 845-256-1093 | |
Lisa Thorn, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 144 Overhill Rd, Middletown, NY 10940 Phone: 845-344-2609 | |
Ms. Catherine A Guzman, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 16 Union Street, Middletown, NY 10940 Phone: 845-343-5556 | |
Ms. Donette Smith, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 45 Ashley Ave, Act Team, Middletown, NY 10940 Phone: 845-326-8073 | |
Mr. Thomas Davide Palmieri, LMSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 16-24 Union Street, Middletown, NY 10940 Phone: 845-343-5556 |